AL-15469A for the Treatment of Bacterial Conjunctivitis

NCT00332293 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

695

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Conjunctivitis

Interventions

DRUG: Moxifloxacin Alternative Formulation Ophthalmic Solution 0.5%
DRUG: Moxifloxacin hydrochloride ophthalmic solution 0.5% as base

Sponsor

Alcon Research